High Acceptability and Safety of Out-of-Hospital Cabotegravir and Rilpivirine Administration (HOLA Study)

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026


High Acceptability and Safety of Out-of-Hospital Cabotegravir and Rilpivirine Administration (HOLA Study)

	CROI 2026 Feb 22-25 Denver Eugenia Negredo1,2,3, Diana Hernández-Sanchez1, Àngel Rivero1,4, Patricia Álvarez-López5, Vicenç Falcó6, Javier Jusmet7, Jordi Puig1, Félix Pérez7, Damaris Aguilar8, Miguel Angel Cuerda9, Ana Belén Flores10, José Manuel Pavón11, David Rovira1, Cristian Tebe12, Julián Olalla8